is bupropion a glp 1 drug GLP-1 anti-obesity medicines remain too expensive Add-On to GLP-1s Yields Greater

Pemvidutide, a GLP-1/glucagon dual receptor agonist, significantly reduces liver fat, fibro-inflammation, and body weight in patients with non-alcoholic fatty liver disease: a 24-week multicenter, randomized, double-blind, placebo-controlled trial

While on Semaglutide GLP-1, there are some precautions you need to consider

doi:10.1038/nm1196-1254 303

Notably, a dose-dependent increase in heart rate, peaking at 24 weeks, subsequently decreased [19]

Liao T, Zhang SL, Yuan X, et al

Patients typically experience reductions in HbA1c (glycated haemoglobin) of approximately 1.01.5% (1116 mmol/mol) when added to existing therapy, with some agents achieving even greater reductions